2,4-diamino-5-(3,4-dimethoxybenzyl)pyrimidine,
diaveridine,
diaveridine monohydrochloride,
EGIS-5645,
DIAVERIDINE,
5355-16-8,
Diaveridin,
Diaveridinum,
Diaveridina,
2,4-Diamino-5-veratrylpyrimidine,
5-(3,4-dimethoxybenzyl)pyrimidine-2,4-diamine,
2,4-Diamino-5-(3,4-dimethoxybenzyl)pyrimidine,
BW 49-210,
5-((3,4-Dimethoxyphenyl)methyl)-2,4-pyrimidinediamine,
Diaveridinum [INN-Latin],
Diaveridina [INN-Spanish],
UNII-7KVX81XA87,
5-[(3,4-dimethoxyphenyl)methyl]pyrimidine-2,4-diamine,
Pyrimidine, 2,4-diamino-5-veratryl-,
Diaveridine [USAN:INN:BAN],
CCRIS 3784,
AI3-23935,
EGIS 5645,
EGIS-5645,
CHEBI:123115,
EINECS 226-333-3,
NSC 408735,
5-(3,4-Dimethoxy-benzyl)-pyrimidine-2,4-diamine,
BRN 0258464,
CHEMBL19633,
2,4-Pyrimidinediamine, 5-[(3,4-dimethoxyphenyl)methyl]-,
7KVX81XA87,
5-(3,4-Dimethoxybenzyl)-2,4-pyrimidinediamine,
LDBTVAXGKYIFHO-UHFFFAOYSA-N,
C13H16N4O2,
MFCD00057349,
NSC408735,
NSC-408735,
NCGC00160517-01,
DSSTox_CID_26200,
DSSTox_RID_81431,
DSSTox_GSID_46200,
W-105726,
2,4-Pyrimidinediamine, 5-((3,4-dimethoxyphenyl)methyl)-,
CAS-5355-16-8,
Diverdine,
AC1L2ICY,
AC1Q4CFM,
Diaveridine (USAN/INN),
Epitope ID:119685,
SCHEMBL93896,
2,4-Diamino-5-(3',4'-dimethoxybenzyl)pyrimidine,
5-25-13-00391 (Beilstein Handbook Reference),
MLS004712092,
2,4-dimethoxybenzyl)pyrimidine,
CCRIS-3784,
DTXSID2046200,
CTK8F9123,
ZINC24946,
Pyrimidine,4-diamino-5-veratryl-,
HMS3264I16,
Pharmakon1600-01502300,
HY-B1902,
Tox21_111866,
BBL009897,
BDBM50138691,
NSC759634,
STK711076,
AKOS005530708,
Tox21_111866_1,
API0002306,
CCG-213021,
MCULE-5322777872,
NSC-759634,
VA10713,
2, 5-[(3,4-dimethoxyphenyl)methyl]-,
NCGC00160517-02,
NCGC00160517-03,
AC-12110,
AJ-08448,
BW 49210,
BW-49210,
CC-26450,
Diaveridine 10 microg/mL in Acetonitrile,
P787,
SMR002529995,
ST082353,
ZB000803,
LS-134998,
AK00037240,
CS-0013961,
FT-0603089,
Pyrimidine, 2,4-diamino-5-veratryl- (8CI),
210U49,
D03771,
AB01562957_01,
Diaveridine, VETRANAL(TM), analytical standard,
355D168,
5-(3,4-Dimethoxybenzyl)-2,4-pyrimidinediamine #,
A829660,
C-16247,
SR-01000939849,
2,4-diamino-5-(3',4'-dimethoxybenzyl) pyrimidine,
2,4-diamino-5-(3',4'-dimethoxybenzyl)-pyrimidine,
Diaveridine, analytical standard, >=99.0% (TLC),
SR-01000939849-2,
Diaveridine, United States Pharmacopeia (USP) Reference Standard,
Diaveridine < Rec INN,
D0FC5T,
Diaveridine [USAN:BAN:INN],
Diaveridine, 98% - 1G 1g,
CID21453,
C13-H16-N4-O2,
C(c1ccc(OC)c(OC)c1)c2cnc(N)nc2N,
CS-O-11990,
1ST21042,
5-[(3,4-Dimethoxyphenyl)methyl]-2,4-pyrimidinediamine,
BAN,